{"id":"W2748599797","doi":"10.1136/esmoopen-2017-000219","title":"Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer","year":2017,"lang":"en","type":"article","venue":"ESMO Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Cancer Research UK; Pfizer","keywords":"Crizotinib; Medicine; Internal medicine; Lung cancer; Tolerability; Anaplastic lymphoma kinase; Response Evaluation Criteria in Solid Tumors; ALK inhibitor; Oncology; Adverse effect; Population; Clinical trial; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004905536,0.0009066362,0.001032267,0.0001710542,0.0003699294,0.0009079289,0.0005458799,0.0008456882,0.003372898],"category_scores_gemma":[0.002925152,0.0003219585,0.00162739,0.0002993505,0.0004624933,0.0005998039,0.000393067,0.002119394,0.0008470849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009970203,"about_ca_system_score_gemma":0.002034369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001527757,"about_ca_topic_score_gemma":0.005476316,"domain_scores_codex":[0.9988355,0.0006531518,0.0001009358,0.0001652094,0.000132718,0.0001124249],"domain_scores_gemma":[0.9986728,0.0002929496,0.0003411247,0.0001628129,0.0001877207,0.0003426339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7542361,0.01376652,0.02903594,0.001406497,0.006261071,0.0003248557,0.0003069015,0.003613501,0.02742509,0.0003340926,0.02980513,0.1334842],"study_design_scores_gemma":[0.5882142,0.2449864,0.1185212,0.0002705124,0.005761053,0.001124439,0.0001387453,0.003175899,0.009318427,0.0007421714,0.02763694,0.0001100339],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624984,0.006624336,0.001968559,0.001952743,0.0002515351,0.004640534,0.01252938,0.0002313357,0.009303101],"genre_scores_gemma":[0.9584211,0.001968732,0.003596016,0.002191647,0.0001591465,0.003697793,0.02624935,0.00007228334,0.003644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004905536,"threshold_uncertainty_score":0.02594328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01645718667427923,"score_gpt":0.3405032469563614,"score_spread":0.3240460602820821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}